Proposed Extension of Existing Collection; Comment Request, 59842-59843 [2019-24078]

Download as PDF 59842 Federal Register / Vol. 84, No. 215 / Wednesday, November 6, 2019 / Notices Vermont Virginia Virgin Islands Washington West Virginia Wisconsin Wyoming This certification is for the maximum additional credit allowable under Section 3302(b) of the Code, subject to the limitations of Section 3302(c) of the Code. Signed at Washington, D.C., on October 31, 2019. lllllllllllllllllll EUGENE SCALIA [FR Doc. 2019–24216 Filed 11–5–19; 8:45 am] BILLING CODE 4510–FW–P DEPARTMENT OF LABOR Office of Workers’ Compensation Programs Proposed Extension of Existing Collection; Comment Request Divison of Federal Employees’ Compensation, Office of Workers’ Compensation Programs, Labor. ACTION: Notice. AGENCY: The Department of Labor, as part of its continuing effort to reduce paperwork and respondent burden, conducts a preclearance consultation program to provide the general public and Federal agencies with an opportunity to comment on proposed and/or continuing collections of information in accordance with the Paperwork Reduction Act of 1995. This program helps to ensure that requested data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and the impact of collection requirements on respondents can be properly assessed. DATES: Written comments must be submitted to the office listed in the addresses section below on or before January 6, 2020. ADDRESSES: You may submit comments by mail, delivery service, or by hand to Anjanette Suggs, U.S. Department of Labor, 200 Constitution Ave. NW, Room S–3323, Washington, DC 20210; by fax, (202) 354–9660, or email to suggs.anjanette@dol.gov. Please use only one method of transmission for comments (mail or email). SUPPLEMENTARY INFORMATION: I. Background: The purpose of the Paperwork Reduction Act of 1995 (PRA), 44 U.S.C. 3501 et seq., include SUMMARY: VerDate Sep<11>2014 17:43 Nov 05, 2019 Jkt 250001 enhancing the quality and utility of information the Federal government requires and minimizing the paperwork and reporting burden of affected entitities. The public is not required to respond to a collection of information unless it displays a currently valid OMB control number (44 U.S.C. 3507). Also, notwithstanding any other provisions of law, no person shall be subject to penalty for failing to comply with a collection of information if there is not a current valid OMB control number (44 U.S.C. 3512). The DOL is requesting an approval of an extension of this information collection. This information collection is essential to the mission of DOL and the Office of Workers’ Compensation Programs (OWCP), to monitor and assure the appropriate use of opioids and compounded drugs in treating employment-related injuries under the Federal Employees Compensation Act (FECA), 5 U.S.C. 8101 et seq. The FECA statute grants OWCP discretion to provide an injured employee the ‘‘services, appliances, and supplies prescribed or recommended by a qualified physician’’ which OWCP considers ‘‘likely to cure, give relief, reduce the degree or the period of disability, or aid in lessening the amount of the monthly compensation.’’ 5 U.S.C. 8103. In other words, OWCP is mandated to provide medical supplies and services—including prescription drugs such as opioids and compounded drugs—that it considers medically necessary. 20 CFR 10.310. The FECA statute and implementing regulations are not primarily focused on managing doctor/patient decisions relating to medication therapy and, with the exception of few limitations on fentanyl (an opioid) and other controlled substances, the FECA program policy on pharmacy benefits has generally been a policy of payment for prescribed medications in accordance with a fee schedule based on a percentage of the average wholesale price (AWP) for drugs identified by a National Drug Code (NDC). See 20 CFR 10.809. To this end, the FECA program has a prior authorization policy (based on medical necessity) for opioid and compounded drugs utilizing the pre-authorization authority already contained in its regulations at 20 CFR 10.310(a) and § 10.800(b). Information collected on the CA–26 and the CA–27, require an injured worker’s treating physician to answer a number of questions about the prescribed opioids and/or compounded drugs and certify that they are medically necessary to treat the work-related injury. The responses to the questions PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 on the forms are intended to ensure that treating physicians have considered non-opioid and non-compounded drug alternatives, and are only prescribing the most cost effective and medically necessary drugs. The forms also permit OWCP to more easily track the volume, type, and characteristics of opioids and compounded drugs authorized by the FECA program. The forms serve as a means for injured workers to continue receiving opioids and compounded drugs only where medically necessary and simultaneously give OWCP greater oversight in monitoring their appropriate use and gather additional data about their use. II. Review Focus: The DOL is particularly interested in comments which: * Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; * evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; * enhance the quality, utility and clarity of the information to be collected; and * minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. III. Current Actions: The DOL seeks the approval for the extension of this currently approved information collection in order to carry out its responsibility to meet the statutory requirements of the Federal Employees’ Compensation Act. Agency: Office of Workers’ Compensation Programs. Type of Review: Extension. Title: Authorization and Certification/ Letter of Medical Necessity. OMB Number: 1240–0055. Agency Number: CA–26 and CA–27. Affected Public: Individuals or households; Businesses or other forprofit. Total Respondents: 45,600. Total Annual Responses: 45,600. Estimated Total Burden Hours: 22,800. Estimated Time per Response: 30 minutes. Frequency: On occasion. Total Burden Cost (capital/startup): $0. E:\FR\FM\06NON1.SGM 06NON1 Federal Register / Vol. 84, No. 215 / Wednesday, November 6, 2019 / Notices Total Burden Cost (operating/ maintenance): $0. Comments submitted in response to this notice will be summarized and/or included in the request for Office of Management and Budget approval of the information collection request; they will also become a matter of public record. Ajanette Suggs, Agency Clearance Officer, Office of Workers’ Compensation Programs, US Department of Labor. [FR Doc. 2019–24078 Filed 11–5–19; 8:45 am] BILLING CODE 4510–CH–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice: (19–078)] National Space-Based Positioning, Navigation, and Timing Advisory Board; Meeting National Aeronautics and Space Administration (NASA). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, as amended, and the President’s 2004 U.S. Space-Based Positioning, Navigation, and Timing (PNT) Policy, the National Aeronautics and Space Administration (NASA) announces a meeting of the National Space-Based Positioning, Navigation, and Timing (PNT) Advisory Board. DATES: Wednesday, November 20, 2019, 8:30 a.m. to 5:30 p.m.; and Thursday, November 21, 2019, 8:30 a.m. to 1:00 p.m., Local Time. ADDRESSES: Hilton Cocoa Beach Oceanfront, Grand Ballroom, 1550 North Atlantic Ave. Cocoa Beach, Florida, 32931. FOR FURTHER INFORMATION CONTACT: Mr. James J. Miller, Designated Federal Official, Human Exploration and Operations Mission Directorate, NASA Headquarters, Washington, DC 20546, (202) 358–4417, fax (202) 358–4297, or jj.miller@nasa.gov. SUPPLEMENTARY INFORMATION: The meeting will be open to the public up to the seating capacity of the room. It is imperative that the meeting be held on these dates to accommodate the scheduling priorities of the key participants. Visitors will be requested to sign a visitor’s register. The agenda for the meeting includes the following topics: • Update on U.S. Space-Based Positioning, Navigation and Timing (PNT) Policy and Global Positioning System (GPS) modernization. SUMMARY: VerDate Sep<11>2014 17:43 Nov 05, 2019 Jkt 250001 59843 • Prioritize current and planned GPS capabilities and services while assessing future PNT architecture alternatives with a focus on affordability. • Examine methods in which to Protect, Toughen, and Augment (PTA) access to GPS/Global Navigation Satellite Systems (GNSS) services in key domains for multiple user sectors. • Assess economic impacts of GPS/ GNSS on the United States and in select international regions, with a consideration towards effects of potential PNT service disruptions if radio spectrum interference is introduced. • Review the potential benefits, perceived vulnerabilities, and any proposed regulatory constraints to accessing foreign Radio Navigation Satellite Service (RNSS) signals in the United States and subsequent impacts on multi-GNSS receiver markets. • Explore opportunities for enhancing the interoperability of GPS with other emerging international GNSS. • Examine emerging trends and requirements for PNT services in U.S. and international fora through PNT Board technical assessments, including back-up services for terrestrial, maritime, aviation, and space users. initial appraisal of a senior executive’s performance by the supervisor and considers recommendations to the appointing authority regarding the performance of the senior executive. The following have been designated as members of the 2019 Performance Review Board of the National Transportation Safety Board (NTSB): Mr. Edward Benthall, Chief Financial Officer, National Transportation Safety Board, PRB Chair. Ms. Barbara A. Czech, Deputy Director, Office of Research and Engineering, National Transportation Safety Board. Mr. Jerold Gidner, Principal Deputy Special Trustee, Office of the Special Trustee for American Indians, Department of Interior. Ms. Claudia J. Postell, Associate Commissioner, Office of Civil Rights and Equal Opportunity, Social Security Administration. Mr. Paul S. Sledzik, Deputy Managing Director, National Transportation Safety Board. Ms. Katherine Herrera, Deputy Technical Director, Defense Nuclear Facilities Safety Board (alternate). Ms. Susan A. Kantrowitz, Director, Office of Administration, National Transportation Safety Board (alternate). Carol J. Hamilton, Advisory Committee Management Officer (Acting), National Aeronautics and Space Administration. Dated: November 1, 2019. LaSean R. McCray, Alternate Federal Register Liaison. [FR Doc. 2019–24201 Filed 11–5–19; 8:45 am] [FR Doc. 2019–24217 Filed 11–5–19; 8:45 am] BILLING CODE 7533–01–P BILLING CODE 7510–13–P NATIONAL TRANSPORTATION SAFETY BOARD SES Performance Review Board AGENCY: National Transportation Safety Board. ACTION: Notice. Notice is hereby given of the appointment of members of the National Transportation Safety Board, Performance Review Board (PRB). FOR FURTHER INFORMATION CONTACT: Emily T. Carroll, Chief, Human Resources Division, Office of Administration, National Transportation Safety Board, 490 L’Enfant Plaza SW, Washington, DC 20594–0001, (202) 314– 6233. SUPPLEMENTARY INFORMATION: Section 4314(c)(1) through (5) of Title 5, United States Code requires each agency to establish, in accordance with regulations prescribed by the Office of Personnel Management, one or more SES Performance Review Boards (PRB). The board reviews and evaluates the SUMMARY: PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 NUCLEAR REGULATORY COMMISSION [Docket No. 11006367; NRC–2019–0213] Perma-Fix Northwest Richland, Inc. Nuclear Regulatory Commission. ACTION: Export license application; opportunity to comment, request a hearing, and petition for leave to intervene. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is considering issuing an export license (XW025), requested by Perma-Fix Northwest Richland, Inc. (PFNW). On September 27, 2019, PFNW filed an application with the NRC for a license to export radioactive waste. The request seeks NRC approval for the export of low-level radioactive waste to Italy. The NRC is providing notice of the opportunity to request a hearing on PFNW’s revised application. The request seeks the NRC’s approval of the application authorizing the export of radioactive waste to Italy. SUMMARY: E:\FR\FM\06NON1.SGM 06NON1

Agencies

[Federal Register Volume 84, Number 215 (Wednesday, November 6, 2019)]
[Notices]
[Pages 59842-59843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24078]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Office of Workers' Compensation Programs


Proposed Extension of Existing Collection; Comment Request

AGENCY: Divison of Federal Employees' Compensation, Office of Workers' 
Compensation Programs, Labor.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Labor, as part of its continuing effort to 
reduce paperwork and respondent burden, conducts a preclearance 
consultation program to provide the general public and Federal agencies 
with an opportunity to comment on proposed and/or continuing 
collections of information in accordance with the Paperwork Reduction 
Act of 1995. This program helps to ensure that requested data can be 
provided in the desired format, reporting burden (time and financial 
resources) is minimized, collection instruments are clearly understood, 
and the impact of collection requirements on respondents can be 
properly assessed.

DATES: Written comments must be submitted to the office listed in the 
addresses section below on or before January 6, 2020.

ADDRESSES: You may submit comments by mail, delivery service, or by 
hand to Anjanette Suggs, U.S. Department of Labor, 200 Constitution 
Ave. NW, Room S-3323, Washington, DC 20210; by fax, (202) 354-9660, or 
email to [email protected]. Please use only one method of 
transmission for comments (mail or email).

SUPPLEMENTARY INFORMATION: 
    I. Background: The purpose of the Paperwork Reduction Act of 1995 
(PRA), 44 U.S.C. 3501 et seq., include enhancing the quality and 
utility of information the Federal government requires and minimizing 
the paperwork and reporting burden of affected entitities. The public 
is not required to respond to a collection of information unless it 
displays a currently valid OMB control number (44 U.S.C. 3507). Also, 
notwithstanding any other provisions of law, no person shall be subject 
to penalty for failing to comply with a collection of information if 
there is not a current valid OMB control number (44 U.S.C. 3512).
    The DOL is requesting an approval of an extension of this 
information collection. This information collection is essential to the 
mission of DOL and the Office of Workers' Compensation Programs (OWCP), 
to monitor and assure the appropriate use of opioids and compounded 
drugs in treating employment-related injuries under the Federal 
Employees Compensation Act (FECA), 5 U.S.C. 8101 et seq.
    The FECA statute grants OWCP discretion to provide an injured 
employee the ``services, appliances, and supplies prescribed or 
recommended by a qualified physician'' which OWCP considers ``likely to 
cure, give relief, reduce the degree or the period of disability, or 
aid in lessening the amount of the monthly compensation.'' 5 U.S.C. 
8103. In other words, OWCP is mandated to provide medical supplies and 
services--including prescription drugs such as opioids and compounded 
drugs--that it considers medically necessary. 20 CFR 10.310. The FECA 
statute and implementing regulations are not primarily focused on 
managing doctor/patient decisions relating to medication therapy and, 
with the exception of few limitations on fentanyl (an opioid) and other 
controlled substances, the FECA program policy on pharmacy benefits has 
generally been a policy of payment for prescribed medications in 
accordance with a fee schedule based on a percentage of the average 
wholesale price (AWP) for drugs identified by a National Drug Code 
(NDC). See 20 CFR 10.809. To this end, the FECA program has a prior 
authorization policy (based on medical necessity) for opioid and 
compounded drugs utilizing the pre-authorization authority already 
contained in its regulations at 20 CFR 10.310(a) and Sec.  10.800(b).
    Information collected on the CA-26 and the CA-27, require an 
injured worker's treating physician to answer a number of questions 
about the prescribed opioids and/or compounded drugs and certify that 
they are medically necessary to treat the work-related injury. The 
responses to the questions on the forms are intended to ensure that 
treating physicians have considered non-opioid and non-compounded drug 
alternatives, and are only prescribing the most cost effective and 
medically necessary drugs. The forms also permit OWCP to more easily 
track the volume, type, and characteristics of opioids and compounded 
drugs authorized by the FECA program. The forms serve as a means for 
injured workers to continue receiving opioids and compounded drugs only 
where medically necessary and simultaneously give OWCP greater 
oversight in monitoring their appropriate use and gather additional 
data about their use.
    II. Review Focus: The DOL is particularly interested in comments 
which:
    * Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    * evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    * enhance the quality, utility and clarity of the information to be 
collected; and
    * minimize the burden of the collection of information on those who 
are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    III. Current Actions: The DOL seeks the approval for the extension 
of this currently approved information collection in order to carry out 
its responsibility to meet the statutory requirements of the Federal 
Employees' Compensation Act.
    Agency: Office of Workers' Compensation Programs.
    Type of Review: Extension.
    Title: Authorization and Certification/Letter of Medical Necessity.
    OMB Number: 1240-0055.
    Agency Number: CA-26 and CA-27.
    Affected Public: Individuals or households; Businesses or other 
for-profit.
    Total Respondents: 45,600.
    Total Annual Responses: 45,600.
    Estimated Total Burden Hours: 22,800.
    Estimated Time per Response: 30 minutes.
    Frequency: On occasion.
    Total Burden Cost (capital/startup): $0.

[[Page 59843]]

    Total Burden Cost (operating/maintenance): $0.
    Comments submitted in response to this notice will be summarized 
and/or included in the request for Office of Management and Budget 
approval of the information collection request; they will also become a 
matter of public record.

Ajanette Suggs,
Agency Clearance Officer, Office of Workers' Compensation Programs, US 
Department of Labor.
[FR Doc. 2019-24078 Filed 11-5-19; 8:45 am]
 BILLING CODE 4510-CH-P